CYMBALTA: Five Patients Commit Suicide During Clinical Trials: U.S.A.

Cymbalta manufactured by Eli Lilly is a serotonin norepinephrine reuptake inhibitor (SNRI) antidepressant used to treat major depression. It is prescribed to treat pain associated with diabetic peripheral neuropathy, which is a painful nerve disorder associated with diabetes that affects the hands, legs, and feet. Cymbalta has only recently been approved for use to treat fibromyalgia if people can tolerate Cymbalta’s side effects.

The drug works by preventing serotonin and noradrenaline from being reabsorbed back into the nerve cells in the brain. This helps prolong the mood-lightening effect of any released serotonin and noradrenaline, restoring balance to the emotions of the patient. Cymbalta may also be used in the treatment of generalized anxiety disorder.

Read More

3/30/2001 – 60 Minutes Show, April 1 – Clinical Drug Trial Dangers

“Clinical Drug Trial Dangers?”

On Sunday, April 1, at 7 p.m. ET/PT, CBS 60 Minutes will air a
segment entitled “Of Mice And Men.” Steve Kroft reports that
patients taking experimental drugs in clinical trials often don’t
know the doctors administering them are usually being paid by
the drug companies and that the drugs can sometimes worsen
their health.

Read More